Gabriele Dragoni, Tommaso Innocenti, Aurelién Amiot, Fabiana Castiglione, Laura Melotti, Stefano Festa, Edoardo Vincenzo Savarino, Marie Truyens, Konstantinos Argyriou, Daniele Noviello, Tamas Molnar, Vincent Bouillon, Cristina Bezzio, Piotr Eder, Samuel Fernandes, Anna Kagramanova, Alessandro Armuzzi, Raquel Oliveira, Anna Viola, Davide Giuseppe Ribaldone, Ioannis Drygiannakis, Chiara Viganò, Francesca Calella, Antonietta Gerarda Gravina, Daniela Pugliese, María Chaparro, Pierre Ellul, Sophie Vieujean, Monica Milla, Flavio Caprioli
BACKGROUND AND AIMS: Patients with ulcerative colitis (UC) receiving immunosuppressive drugs are at substantial risk of colectomy. We aimed to assess the risk of post-operative complications of tofacitinib exposure before colectomy in comparison with biologics. METHODS: A multicentre, retrospective, observational study was conducted in patients with UC who underwent total colectomy for medically refractory disease, exposed to tofacitinib or a biologic before surgery...
February 2, 2024: American Journal of Gastroenterology